Navigation Links
Five New Clinical Studies Show Value of Masimo PVI & PI
Date:10/17/2008

ion 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that Masimo PVI and total hemoglobin (SpHb(TM)) will deliver a sufficient level of clinical improvement over alternative fluid assessment and hemoglobin measurement capabilities to allow for rapid adoption of the technology, risks related to our assumptions regarding the repeatability of clinical results, and risks related to our assumptions regarding timing or commercial availability of SpHb, as well as other factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter ended June 28, 2008, filed with the Securities and Exchange Commission ("SEC") on August 5, 2008, which may be obtained for free at the SEC's website at http://www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our Quarterly Report on Form 10-Q for the fiscal quarter ended June 28, 2008, whether as a
'/>"/>
SOURCE Masimo
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
2. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
3. ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development
4. Sysmex Announces Clinical Laboratory Software Name Change
5. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
6. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Satyam Partners with Oracle to Provide Clinical Development Applications
9. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
10. Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
11. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... (PRWEB) November 23, 2014 One of the ... of optics and photonics is now available to high school ... low cost. SPIE, the international society for optics and ... the complete SPIE Digital Library available to high ... , “Light-based technologies are integral to all areas of life ...
(Date:11/24/2014)... Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix v. ... both in the United States District Court for ... . On November 21, 2014 ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 During his ... understood the need to surround himself with great people ... and entrepreneur, his friends often marveled at his extraordinarily ... lived his life and -- even with his death ... the Alzheimer’s disease that would ultimately take his life. ...
(Date:11/22/2014)... On November 17th Chicago start-up Briteseed outperformed ... Technologies Summit in San Francisco to take first place ... Silicon Valley investors and technology elites as the premier ... positions Briteseed to move on to the final ... compete with other elite innovation finalists for a $125,000 ...
Breaking Biology Technology:SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3
... Research & Development Team, CLINTON, N.J., ... fully,integrated critical care biotherapeutics company, announced that ... President of Translational,Medicine, reporting to Ralf Rosskamp, ... of Ikaria., As Vice President of ...
... Thursday, June 26th at 2:30pm ET, NEW YORK, ... today announced that Michael S. Weiss, the Company,s,Chairman and ... & Co. Healthcare Conference being held in New York ... on Thursday, June 26th at,2:30pm ET and will be ...
... New Generation Biofuels,Holdings, Inc. (AMEX: GNB ), a ... Exchange (AMEX) in mid-April, will join the Russell,Microcap Index ... Friday, June 27th, after the market closes, according to ... ., Membership in the Russell Microcap Index, which ...
Cached Biology Technology:Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 2Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 3Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2New Generation Biofuels Set to Join Russell Microcap Index 2New Generation Biofuels Set to Join Russell Microcap Index 3
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... issue of Physics World , James Dacey explores ... of death" to take their innovations from the lab ... gruelling challenge facing all start-up companies as they move ... because of two main factors: physics-based inventions are usually ... turn out to be a lot more complicated than ...
(Date:11/2/2014)... put a flashlight up to our palms to see ... St. Louis engineers are using a similar idea to ... of cancerous tissues and to develop potential treatments. ... Professor of Biomedical Engineering at the School of Engineering ... that allows researchers to better focus light in tissue, ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2Improving imaging of cancerous tissues by reversing time 2
... 2008) Argonne National Laboratory has signed a ... Laboratory (SRNL) to collaborate on nuclear energy and ... U.S. Energy Department (DOE) needs and other important ... remain a leader in nuclear energy research," Argonne ...
... the molecule hydroxyl on another planet for the first ... to unlock the workings of Venuss dense atmosphere. ... of a hydrogen and oxygen atom each. It has ... atmosphere, some 100 km above the surface, by Venus ...
... tea may be able to stave off the cognitive ... to a new study published in the second issue ... of Respiratory and Critical Care Medicine. Researchers examined ... water, on rats who were intermittently deprived of oxygen ...
Cached Biology News:Argonne-SRNL agreement supports critical DOE, national priorities 2Key molecule discovered in Venus's atmosphere 2Green tea compounds beat OSA-related brain deficits 2
...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
... Activation of ICE-family proteases/caspases initiates apoptosis in ... Apoptosis Detection Kit provides a simple and ... by flow cytometry in intact cells. ... two aspartate residues linked to rhodamine 110 ...
Biology Products: